Systematic Review of Interleukin-35 in Endothelial Dysfunction: A New Target for Therapeutic InterventionMEDIATORS OF INFLAMMATIONIF4.22025-02-120OA
Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis关键细胞外蛋白作为复发-缓解型多发性硬化潜在生物标志物的鉴定和临床验证FRONTIERS IN IMMUNOLOGYIF5.92021-12-0722OAAI
Interleukin-35 inhibits lipopolysaccharide-induced endothelial cell activation by downregulating inflammation and apoptosisEXPERIMENTAL CELL RESEARCHIF3.52021-10-0122PREAI
Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrotic reactionsINTERNATIONAL IMMUNOPHARMACOLOGYIF4.72020-09-0130OAAI
5-O-methyldihydroquercetin and cilicicone B isolated from Spina Gleditsiae ameliorate lipopolysaccharide-induced acute kidney injury in mice by inhibiting inflammation and oxidative stress via the TLR4/MyD88/TRIF/NLRP3 signaling pathwayINTERNATIONAL IMMUNOPHARMACOLOGYIF4.72020-03-0119PREAI
Corticotropin-releasing Factor Changes the Phenotype and Function of Dendritic Cells in Mouse Mesenteric Lymph Nodesneurogastroenterology and motilityIF3.32015-10-017OAAI
Febrifugine analogue compounds: Synthesis and antimalarial evaluationBIOORGANIC & MEDICINAL CHEMISTRYIF32012-01-0141OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项